雅培（ABT，下跌 1.55%）计划将其营养业务分拆为一家独立公司，年销售额约为 85 亿美元。
Abbott ABT -1.55%decrease; down pointing triangle plans to separate its nutrition business into an independent company with about $8.5 billion in annual sales.
目前担任雅培成熟制药与营养产品部门执行副总裁兼集团总裁的 Daniel Salvadori 将领导这家新公司，旗下将拥有电解质饮料品牌 Pedialyte 和婴儿配方奶粉品牌 Similac。
Daniel Salvadori, who currently serves as executive vice president and group president of Abbott’s established pharmaceuticals and nutritional products division, will lead the new company, which will house electrolyte-beverage brand Pedialyte and infant-formula brand Similac.